cyclosporine and Primary Graft Dysfunction

cyclosporine has been researched along with Primary Graft Dysfunction in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buist, L; Clancy, M; Daly, C; Geddes, CC; Jardine, AG; Kingsmore, D; McGregor, E; McManus, S; McMillan, M; Murio, E; Padmanabhan, N; Rodger, RS; Shumeyko, V1
Aljurf, MD; Amrolia, PJ; Bacigalupo, A; Bader, P; Bhatnagar, N; Carraro, E; de la Fuente, J; Dufour, C; Ewins, AM; Gibson, B; Hochsmann, B; Hough, RE; Kulasekararaj, A; Marsh, JC; Passweg, J; Peffault de Latour, R; Pillon, M; Risitano, AM; Rovo, A; Samarasinghe, S; Schrezenmeier, H; Skinner, R; Socie, G; Steward, CG; Tichelli, A; van Biezen, A; Velangi, M; Veys, P; Vora, AJ; Wynn, R1
Glowacki, F; Hazzan, M; Lionet, A; Noël, C; Provot, F1
Majidi, R; Moghaddasi, S; Nouri-Majalan, N1

Reviews

1 review(s) available for cyclosporine and Primary Graft Dysfunction

ArticleYear
[Immunosuppressive strategies and chronic graft dysfunction in kidney transplantation].
    Nephrologie & therapeutique, 2008, Volume: 4 Suppl 3

    Topics: Calcineurin Inhibitors; Cyclosporine; Fibrosis; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Kidney Tubular Necrosis, Acute; Mycophenolic Acid; Patient Selection; Primary Graft Dysfunction; Randomized Controlled Trials as Topic; Risk

2008

Other Studies

3 other study(ies) available for cyclosporine and Primary Graft Dysfunction

ArticleYear
Five-year outcomes after a change from a cyclosporin-based to a 'low-dose' tacrolimus-based primary immunosuppression regimen for incident kidney transplants--the Glasgow experience.
    Clinical transplants, 2012

    Topics: Adult; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney Transplantation; Male; Middle Aged; Primary Graft Dysfunction; Scotland; Tacrolimus; Treatment Outcome

2012
Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working P
    British journal of haematology, 2015, Volume: 171, Issue:4

    Topics: Adenoviridae Infections; Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Blood Transfusion; Bone Marrow Transplantation; Case-Control Studies; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Herpesviridae Infections; Histocompatibility; Humans; Immunosuppressive Agents; Infant; Kaplan-Meier Estimate; Length of Stay; Living Donors; Male; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Primary Graft Dysfunction; Quality of Life; Retrospective Studies; Siblings; Survival Rate; T-Lymphocytes; Treatment Outcome; Virus Activation; Young Adult

2015
Impaired kidney allograft function following ezetimibe therapy.
    Iranian journal of kidney diseases, 2011, Volume: 5, Issue:2

    Topics: Anticholesteremic Agents; Azetidines; Creatinine; Cyclosporine; Ezetimibe; Humans; Kidney Transplantation; Male; Middle Aged; Primary Graft Dysfunction

2011